P53 protein and its messenger ribonucleic acid in human adrenal tumors

Journal of Endocrinological Investigation

Volumn 21, Issue 11, 1998, Pages 753-757

  Adleff, V ^a   Racz K ^a,c   Toth M ^a   Varga, I ^a   Bezzegh, A ^b   Glaz E ^d  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d NONE

Author keywords

Adrenal; Adrenal pathophysiology; Luminometric immunoassay; p53 expression; p53 protein; Tumors

Indexed keywords

ALDOSTERONE; MESSENGER RNA; PROTEIN P53;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; GANGLIONEUROMA; HEMANGIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYELOLIPOMA; NORTHERN BLOTTING; PHEOCHROMOCYTOMA; PROTEIN CONTENT; TUMOR SUPPRESSOR GENE;

EID: 0032436005     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348041     Document Type: Article

References (18)

1. Levine A.J., Momand J., Finlay C.A. The p53 suppressor gene. Nature 351: 453, 1991.
2. Lane D.P. p53, guardian of the genome. Nature 358: 15, 1992.
3. Bates S., Vousden K.H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6: 12, 1996.
4. Yano T., Linehan M., Anglard P., Lerman M.I., Daniel L.N., Stein C.A., Robertson C.N., LaRocca R., Zbar B. Genetic changes in human adrenocortical carcinomas. J.Natl. Cancer Inst. 81: 518, 1989.
5. Ohgaki H., Kleihues P., Heitz P.U. p53 mutations in sporadic adrenocortical tumors. Int. J. Cancer. 54: 408, 1993.
6. Reincke M., Karl M., Travis W.H., Mastorakos G., Allolio B., Linehan H.M., Chrousos G.P. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J. Clin. Endocrinol. Metab. 78: 790, 1994.
7. Lin S.-R., Lee Y.-J., Tsai J.-H. Mutations of the p53 gene in human functional adrenal neoplasms. J. Clin. Endocrinol. Metab. 78: 483, 1994.
8. Dahia P.L.M., Aguiar R.C.T., Tsanaclis A.M., Bendit I., Bydlowski S.P., Abelin N.M.A., Toledo S.P.A. Molecular and immunohistochemical analysis of p53 in phaeochromocytoma. Br. J. Cancer 72: 1211, 1995.
9. Glicquel C., Bertagna X., LeBouc Y. Recent advances in the pathogenesis of adrenocortical tumours. Eur. J. Endocrinol. 133: 133, 1995.
10. Reincke M., Wachenfeld C., Mora P., Thumser A., Jaursch-Hancke C., Abdelhamid S., Chrousos G.P., Allolio B. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. J. Clin. Endocrinol. Metab. 81: 3636, 1996.
11. Vojtesek B., Fisher C.J., Barnes D.M., Lane D.P. Comparison between p53 staining in tissue sections and p53 levels measured by an ELISA technique. Br. J. Cancer 67: 1254, 1993.
12. Borg A., Lennerstrand J., Stenmark-Askmalm M., Fernö M., Brisfors A., Öhrvik A., Stal O., Killander D., Lalle D., Brundell J. Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. Br. J. Cancer. 71: 1013, 1995.
13. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294, 1979.
14. Chomczynki P., Saachi N. Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156, 1997.
15. Rácz K., Pinet F., Marton T., Szende B., Gláz E., Corvol P. Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and "non-functioning" adrenal adenomas. J. Clin. Endocrinol. Metab. 77: 677, 1993.
16. Baker S.J., Markowitz S., Fealon E.R., Willson J.K., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912, 1990.
17. Reincke M., Travis W., Chrousos G.P. Immunohisctochemical evidence for p53 mutations in human adrenal neoplasms. Exp. Clin. Endocrinol. 101 (Suppl. 1): 176 (Abs.), 1993.
18. Hildesheim A., Herrero R., Johnson J., Bratti C., Bhatia K., Magrath I.T., Fraumeni J.F.Jr. Elevated levels of p53 protein in adrenocortical carcinomas from Costa Rica. Eur. J. Cancer. 31: 125, 1995.